Apr 12, 2019, 07:00 ET
CHICAGO, April 12, 2019 /PRNewswire/ -- According to the new market research report "European Hemostats and Sealants Market by Brand Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C.R Bard), Sangustop (B Braun) & Lyostypt (B Braun), Country (Germany, UK, France, Italy & Spain), Europe - Forecast to 2022", published by MarketsandMarkets™, the Hemostats And Sealants (Focused Products) Market is projected to reach USD 77 million by 2022 from USD 59 million in 2018, at a CAGR of 7.0%.
Don't miss out on business opportunities in European Hemostats and Sealants Market
Based on focused products, the tachosil is projected to register the highest growth rate during the forecast period
Based on focused products, the market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene and Hemopatch. The tachosil is expected to grow at the highest CAGR during the forecast period. Major reason behind the high growth of the brand is increasing demand amongst the end-users
Browse in-depth TOC on "European Hemostats and Sealants Market"
8 – Tables
6 – Figures
29 – Pages
Get 10% Free Customization on this Report:
Germany commanded the largest share of the market during the forecast period
Based on region, the hemostats and sealants (focused products) market is segmented into Germany, UK, France, Italy and Spain. Germany dominated the hemostats and sealants market in 2017. This is mainly due to the large patient population in the country. The favorable reimbursement scenario for the usage of hemostats in various surgeries in Germany is also driving the growth of this market
Inquiry Before Buying:
Key players operating in the hemostats and sealants (focused products) market include B. Braun (Germany), Medtronic (Ireland), C R Bard (US), Takeda (Japan), and Baxter (US).
Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/european-hemostat-sealant-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Share this article